Go Pro
→ Bezos… DOOMED (From Paradigm Press) (Ad)tc pixel Free APH Stock Alerts

Aphria (APH) Competitors

Aphria logo
C$24.95 +1.07 (+4.48%)
As of 09/11/2026 03:55 PM Eastern
Compare

APH vs. MRV, VRX, APHA, BHC, and MJN

Should you buy Aphria stock or one of its competitors? Aphria's main competitors and comparable companies include Nuvo Pharmaceuticals (MRV), Valeant Pharmaceuticals International (VRX), Aphria (APHA), Bausch Health Companies (BHC), and Cronos Group (MJN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Aphria compare to Nuvo Pharmaceuticals?

Aphria (TSE:APH) and Nuvo Pharmaceuticals (TSE:MRV) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Aphria has a beta of 3.455044, indicating that its share price is 246% more volatile than the broader market. Comparatively, Nuvo Pharmaceuticals has a beta of 0.917796, indicating that its share price is 8% less volatile than the broader market.

Nuvo Pharmaceuticals has a net margin of 20.95% compared to Aphria's net margin of 0.00%. Nuvo Pharmaceuticals' return on equity of 1,180.47% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Nuvo Pharmaceuticals 20.95%1,180.47%5.85%

0.0% of Aphria shares are owned by institutional investors. Comparatively, 1.8% of Nuvo Pharmaceuticals shares are owned by institutional investors. 6.3% of Nuvo Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aphria has higher revenue and earnings than Nuvo Pharmaceuticals. Nuvo Pharmaceuticals is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$29.01B9.88C$4.93BC$0.4358.14
Nuvo PharmaceuticalsC$8.72B3.94C$15.17MC$2.9113.14

In the previous week, Aphria's average media sentiment score of 0.00 equaled Nuvo Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Aphria Neutral
Nuvo Pharmaceuticals Neutral

Summary

Nuvo Pharmaceuticals beats Aphria on 6 of the 11 factors compared between the two stocks.

How does Aphria compare to Valeant Pharmaceuticals International?

Aphria (TSE:APH) and Valeant Pharmaceuticals International (TSE:VRX) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Valeant Pharmaceuticals International N/A N/A N/A

0.0% of Aphria shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Aphria has higher revenue and earnings than Valeant Pharmaceuticals International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$29.01B9.88C$4.93BC$0.4358.14
Valeant Pharmaceuticals InternationalN/AN/AN/AN/AN/A

In the previous week, Aphria's average media sentiment score of 0.00 equaled Valeant Pharmaceuticals International'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Valeant Pharmaceuticals International Neutral

Summary

Aphria beats Valeant Pharmaceuticals International on 2 of the 2 factors compared between the two stocks.

How does Aphria compare to Aphria?

Aphria (TSE:APH) and Aphria (TSE:APHA) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Aphria N/A N/A N/A

Aphria has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$29.01B9.88C$4.93BC$0.4358.14
AphriaC$611.06M0.00-C$637.39M-C$2.01N/A

In the previous week, Aphria's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Aphria Neutral

0.0% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Aphria beats Aphria on 5 of the 5 factors compared between the two stocks.

How does Aphria compare to Bausch Health Companies?

Aphria (TSE:APH) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Aphria has a net margin of 0.00% compared to Bausch Health Companies' net margin of -12.02%. Bausch Health Companies' return on equity of 87.57% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Bausch Health Companies -12.02%87.57%4.16%

Aphria has a beta of 3.455044, suggesting that its share price is 246% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.707626, suggesting that its share price is 29% less volatile than the broader market.

0.0% of Aphria shares are owned by institutional investors. Comparatively, 9.6% of Bausch Health Companies shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Aphria has higher revenue and earnings than Bausch Health Companies. Bausch Health Companies is trading at a lower price-to-earnings ratio than Aphria, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$29.01B9.88C$4.93BC$0.4358.14
Bausch Health CompaniesC$10.85B0.28-C$125.65M-C$2.94N/A

In the previous week, Bausch Health Companies had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Bausch Health Companies and 0 mentions for Aphria. Bausch Health Companies' average media sentiment score of 0.21 beat Aphria's score of 0.00 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company Overall Sentiment
Aphria Neutral
Bausch Health Companies Neutral

Summary

Aphria and Bausch Health Companies tied by winning 7 of the 14 factors compared between the two stocks.

How does Aphria compare to Cronos Group?

Cronos Group (CVE:MJN) and Aphria (TSE:APH) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

In the previous week, Cronos Group's average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Cronos Group Neutral
Aphria Neutral

0.0% of Aphria shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Cronos GroupN/A N/A N/A
Aphria N/A N/A N/A

Aphria has higher revenue and earnings than Cronos Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupN/AN/AN/AN/AN/A
AphriaC$29.01B9.88C$4.93BC$0.4358.14

Cronos Group pays an annual dividend of C$1.65 per share and has a dividend yield of 13.6%. Aphria pays an annual dividend of C$0.03 per share and has a dividend yield of 0.1%. Aphria pays out 6.1% of its earnings in the form of a dividend.

Summary

Cronos Group and Aphria tied by winning 2 of the 4 factors compared between the two stocks.

Get Aphria News Delivered to You Automatically

Sign up to receive the latest news and ratings for APH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APH vs. The Competition

Export
MetricAphriaPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$273.21BC$12.44BC$7.17BC$12.66B
Dividend Yield0.23%2.63%2.57%6.28%
P/E Ratio58.14660.27214.5740.11
Price / Sales9.88756.95633.769.50
Price / CashN/A88.1776.6582.29
Price / BookN/A10.3910.334.67
Net IncomeC$4.93BC$2.85BC$3.50BC$299.09M
7 Day Performance1.42%-3.61%-3.32%-1.33%
1 Month Performance-1.50%0.86%-0.41%-1.18%
1 Year PerformanceN/A3.47%19.21%23.80%

Aphria Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APH
Aphria
N/AC$24.95
+4.5%		N/AN/AC$273.21BC$29.01B58.1480,000
MRV
Nuvo Pharmaceuticals
N/AC$35.95
+6.4%		N/AN/AC$32.27BC$8.72B12.35N/A
VRX
Valeant Pharmaceuticals International
N/AN/AN/AN/AC$10.76BN/AN/AN/A
APHA
Aphria
N/AN/AN/AN/AC$5.24BC$611.06MN/A1,200
BHC
Bausch Health Companies
0.4878 of 5 stars		C$9.10
-2.4%		N/A-19.3%C$3.40BC$10.85BN/A19,900

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:APH) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners
Elon Musk to Trigger Next AI Wave on November 11th?
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
Why I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)
Don't buy Nvidia... Not when the AI companies that will define the next decade are selling for pennies. You wo...
Decentralized Masters | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
This 38 Dollar Fund Holds Every Major AI Stock and Pays Weekly
The biggest AI stocks like Nvidia, CrowdStrike, and Palantir now trade for hundreds of dollars a share. One fu...
Investors Alley | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
The income “unicorn” Todd Phillips has been waiting 2 years to see again
Retirement income specialist Todd Phillips once tracked an unusual income vehicle nicknamed the 10.3 percent U...
Eagle Publishing | Sponsoredtc pixel
What Is A Roth Conversion, And How Do I Set One Up?
A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax t...
SmartAsset | Sponsoredtc pixel